{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T04:45:32Z","timestamp":1682311532042},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T00:00:00Z","timestamp":1336521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0036384","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T20:58:41Z","timestamp":1336597121000},"page":"e36384","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Genome-Wide siRNA Screen to Identify Modulators of Insulin Sensitivity and Gluconeogenesis"],"prefix":"10.1371","volume":"7","author":[{"given":"Ruojing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul G.","family":"Lacson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino","family":"Castriota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua D.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Miguel","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjad","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenny K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei B.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel P.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0092-8674(01)00239-2","article-title":"New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.","volume":"104","author":"AR Saltiel","year":"2001","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.biocel.2008.06.012","article-title":"c-Jun N-terminal kinase pathways in diabetes.","volume":"40","author":"R Yang","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic.","volume":"414","author":"P Zimmet","year":"2001","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","article-title":"Mechanism by which metformin reduces glucose production in type 2 diabetes.","volume":"49","author":"RS Hundal","year":"2000","journal-title":"Diabetes"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2337\/diabetes.51.1.139","article-title":"Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet.","volume":"51","author":"G Mithieux","year":"2002","journal-title":"Diabetes"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.","volume":"333","author":"M Stumvoll","year":"1995","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"E671","DOI":"10.1152\/ajpendo.00492.2002","article-title":"Glucagon and regulation of glucose metabolism.","volume":"284","author":"G Jiang","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/BF00400461","article-title":"Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats.","volume":"37","author":"CL Brand","year":"1994","journal-title":"Diabetologia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2337\/diabetes.53.2.410","article-title":"Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db\/db mice.","volume":"53","author":"Y Liang","year":"2004","journal-title":"Diabetes"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI20911","article-title":"Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.","volume":"113","author":"KW Sloop","year":"2004","journal-title":"J Clin Invest"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.6278587","article-title":"Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist.","volume":"215","author":"DG Johnson","year":"1982","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1016\/j.bmcl.2008.05.072","article-title":"Discovery of potent, orally active benzimidazole glucagon receptor antagonists.","volume":"18","author":"RM Kim","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1517\/14728222.9.3.593","article-title":"Glucagon as a target for the treatment of Type 2 diabetes.","volume":"9","author":"KW Sloop","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/jm058026u","article-title":"New beta-alanine derivatives are orally available glucagon receptor antagonists.","volume":"50","author":"J Lau","year":"2007","journal-title":"J Med Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2337\/diabetes.53.12.3267","article-title":"A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects.","volume":"53","author":"SA Qureshi","year":"2004","journal-title":"Diabetes"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","article-title":"Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.","volume":"6","author":"MD Michael","year":"2000","journal-title":"Mol Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1172\/JCI16426","article-title":"Insulin signaling is required for insulin\u2019s direct and indirect action on hepatic glucose production.","volume":"111","author":"SJ Fisher","year":"2003","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj20020430","article-title":"New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.","volume":"366","author":"F Foufelle","year":"2002","journal-title":"Biochem J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0092-8674(04)00452-0","article-title":"FoxOs at the crossroads of cellular metabolism, differentiation, and transformation.","volume":"117","author":"D Accili","year":"2004","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1074\/jbc.273.11.6482","article-title":"Protein kinase B\/Akt mediates effects of insulin on hepatic insulin-like growth factor-binding protein-1 gene expression through a conserved insulin response sequence.","volume":"273","author":"SB Cichy","year":"1998","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1210\/endo.140.7.6856","article-title":"FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter.","volume":"140","author":"SK Durham","year":"1999","journal-title":"Endocrinology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"16741","DOI":"10.1074\/jbc.274.24.16741","article-title":"Negative regulation of the forkhead transcription factor FKHR by Akt.","volume":"274","author":"ED Tang","year":"1999","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"17184","DOI":"10.1074\/jbc.274.24.17184","article-title":"Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.","volume":"274","author":"S Guo","year":"1999","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.96.13.7421","article-title":"Protein kinase B\/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1.","volume":"96","author":"WH Biggs","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"15982","DOI":"10.1074\/jbc.274.23.15982","article-title":"Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway.","volume":"274","author":"J Nakae","year":"1999","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/35093050","article-title":"Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.","volume":"413","author":"JC Yoon","year":"2001","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature01667","article-title":"Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.","volume":"423","author":"P Puigserver","year":"2003","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/nature05861","article-title":"Akt\/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator.","volume":"447","author":"X Li","year":"2007","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"31475","DOI":"10.1074\/jbc.272.50.31475","article-title":"Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db\/db transgenic mice.","volume":"272","author":"JE Friedman","year":"1997","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.00253.2003","article-title":"Novel concepts in insulin regulation of hepatic gluconeogenesis.","volume":"285","author":"A Barthel","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2337\/diabetes.51.2.276","article-title":"Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin.","volume":"51","author":"B Huang","year":"2002","journal-title":"Diabetes"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders.","volume":"444","author":"GS Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1210\/endo.136.4.7895667","article-title":"Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in Fao hepatoma cells.","volume":"136","author":"MJ Saad","year":"1995","journal-title":"Endocrinology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/en.2006-0147","article-title":"Minireview: ribonucleic acid interference for the identification of new targets for the treatment of metabolic diseases.","volume":"147","author":"CM Rondinone","year":"2006","journal-title":"Endocrinology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.metabol.2005.01.030","article-title":"Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice.","volume":"54","author":"Y Liang","year":"2005","journal-title":"Metabolism"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/154065802761001310","article-title":"Multiplexed screening assay for mRNA combining nuclease protection with luminescent array detection.","volume":"1","author":"RR Martel","year":"2002","journal-title":"Assay Drug Dev Technol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1087057108317062","article-title":"Novel analytic criteria and effective plate designs for quality control in genome-scale RNAi screens.","volume":"13","author":"XD Zhang","year":"2008","journal-title":"J Biomol Screen"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/1087057107300645","article-title":"A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays.","volume":"12","author":"XD Zhang","year":"2007","journal-title":"J Biomol Screen"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2217\/pgs.09.136","article-title":"Assessing the size of gene or RNAi effects in multifactor high-throughput experiments.","volume":"11","author":"XD Zhang","year":"2010","journal-title":"Pharmacogenomics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0036384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T06:56:19Z","timestamp":1540364179000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0036384"}},"subtitle":[],"editor":[{"given":"John J.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,9]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0036384","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,9]]}}}